Aveanna Healthcare (NASDAQ:AVAH) CAO Sells $80,615.01 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,181 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $80,615.01. Following the sale, the chief accounting officer directly owned 301,807 shares of the company’s stock, valued at $2,176,028.47. This represents a 3.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Deborah Stewart also recently made the following trade(s):

• On Wednesday, February 18th, Deborah Stewart sold 10,896 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.38, for a total transaction of $80,412.48.
• On Tuesday, February 17th, Deborah Stewart sold 7,738 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.65, for a total transaction of $59,195.70.
• On Friday, January 2nd, Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total transaction of $93,901.70.
• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total transaction of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total transaction of $95,128.44.

Aveanna Healthcare Price Performance

NASDAQ AVAH traded up $0.02 on Thursday, hitting $7.42. 3,877,110 shares of the company’s stock were exchanged, compared to its average volume of 938,081. The stock has a 50-day moving average of $8.48 and a 200-day moving average of $8.44. The stock has a market cap of $1.55 billion, a price-to-earnings ratio of 20.61 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39.

Analysts Set New Price Targets

Several research analysts have commented on the company. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Jefferies Financial Group increased their price objective on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research note on Friday, December 5th. Finally, BMO Capital Markets started coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $11.06.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Hedge Funds Weigh In On Aveanna Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd raised its stake in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares during the last quarter. Barclays PLC increased its holdings in Aveanna Healthcare by 0.8% in the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after purchasing an additional 1,366 shares during the period. Franklin Resources Inc. raised its position in Aveanna Healthcare by 4.5% during the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares during the last quarter. Intech Investment Management LLC lifted its holdings in Aveanna Healthcare by 9.8% during the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after buying an additional 1,739 shares during the period. Finally, Balboa Wealth Partners grew its position in shares of Aveanna Healthcare by 13.5% in the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after buying an additional 2,007 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.